publication venue for
- Questionnaire for diagnosis and response to therapy in rumination syndrome. 2024
- Population trends in achalasia diagnosis and management: a changing paradigm.. 34. 2021
- Disparities in esophageal cancer: less treatment, less surgical resection, and poorer survival in disadvantaged patients.. 33. 2020
- Impact of procedural multimedia instructions for pH BRAVO testing on patient comprehension: a prospective randomized study.. 33. 2020
- Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry.. 32. 2019
- Perforated esophageal intervention focus (PERF) study: a multi-center examination of contemporary treatment.. 30. 2017
- Esophagogastric junction outflow obstruction is often associated with coexistent abnormal esophageal body motility and abnormal bolus transit.. 30. 2017
- Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.. 30. 2017
- Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.. 30. 2017
- Worldwide Esophageal Cancer Collaboration: clinical staging data.. 29. 2016
- Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.. 29. 2016
- Worldwide Esophageal Cancer Collaboration: pathologic staging data.. 29. 2016
- Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.. 29. 2015
- Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy.. 29. 2015
- Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?. 28. 2014
- Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008).. 27. 2013
- Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.. 27. 2013
- Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.. 27. 2013
- Recombinant vascular endothelial growth factor165 gene therapy improves anastomotic healing in an animal model of ischemic esophagogastrostomy.. 25. 2011
- Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease.. 25. 2011
- Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons.. 23. 2009
- Psychiatric illness delays diagnosis of esophageal cancer.. 21. 2008
- Acidic fibroblast growth factor is expressed sequentially in the progression from Barrett's esophagus to esophageal adenocarcinoma.. 14. 2001
- Dilatation therapy for dysphagia in patients with upper esophageal sphincter dysfunction--manometric and symptomatic response.. 11. 1998
- Lower esophageal sphincter or upper gastric sphincter?. 10. 1997
- Associated risks of proton pump inhibitors and their influence on prescribing habits: is change truly warranted?. 32. 2019
- Cancer of the esophagus and gastric cardia: recent advances. 2004
- p27 and Barrett's esophagus: a review*. 2004
- Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies. 2020